2020 tables: Institutions - corporate

The 2020 tables are based on Nature Index data from 1 January 2019 to 31 December 2019.

Table criteria

Request a badge Export CSV
# Institution Share 2018 Share 2019 Count 2019 Change in Adjusted Share* 2018–2019
1 Sanofi, France 7.21 4.69 38 -37.0%
2 Thales S.A., France 4.36 4.54 37 0.8%
3 Cellectis SA, France – 2.00 2 N/A
4 L'Oréal International, France 0.29 1.92 3 551.2%
5 Total S.A., France 2.70 1.55 9 -44.4%
6 Ureka - ImmuPharma Group, France – 1.25 2 N/A
7 Ipsen Group, France – 1.24 2 N/A
8 Arkema S.A., France 0.78 1.14 3 42.3%
9 Électricité de France S.A. (EDF), France 0.32 1.02 16 209.3%
10 The Michelin Group, France 0.37 1.01 3 164.4%
11 Saint-Gobain SA, France 0.82 1.00 3 17.7%
12 Innate Pharma S.A., France 0.90 0.94 7 0.7%
13 Veolia Environnement S.A., France 1.07 0.87 2 -21.5%
14 ALomax Scientific, France – 0.67 2 N/A
15 Greenerwave, France 0.35 0.60 2 65.9%
16 Vivet Therapeutics SAS, France – 0.54 1 N/A
17 Estellus, France – 0.53 2 N/A
18 Imabiotech SAS, France – 0.53 2 N/A
19 Ben-Ari Institute of Neuroarcheology, France 0.67 0.46 1 -33.5%
19 Neurochlore, France – 0.46 1 N/A
20 iXBlue SAS, France – 0.42 2 N/A
21 Dassault Systèmes (3DS), France 0.58 0.40 1 -33.6%
21 Technicolor SA, France – 0.40 1 N/A
22 National Metrology and Testing (LNE), France 0.92 0.40 7 -58.6%
23 Sanofi Chimie S.A., France – 0.37 2 N/A
24 Sociétés d’Accélération du Transfert de Technologies (SATT) - Nord, France 0.02 0.36 2 1466.1%
25 Air Liquide, France – 0.34 2 N/A
26 Orano, France 0.29 0.33 1 12.9%
27 Netris Pharma S.A.S., France 0.10 0.29 1 170.9%
28 SIAAP Headquarter, France 0.22 0.29 1 24.4%
29 Servier Laboratories, France 0.83 0.27 2 -68.4%
30 M2i Life Sciences SA, France – 0.26 1 N/A
31 Safran Group, France 0.51 0.26 4 -50.6%
32 Pierre Fabre SA, France 1.43 0.25 1 -83.0%
32 Cetim Grand Est, France – 0.25 1 N/A
32 Adisseo SA, France – 0.25 2 N/A
32 Morphogénie Logiciels SAS, France – 0.25 1 N/A
33 L'Oréal S.A., France 0.35 0.25 2 -32.2%
34 Capital Fund Management (CFM), France – 0.21 1 N/A
35 Bezhin Rosko, France – 0.21 2 N/A
36 Laroche S.A., France – 0.20 1 N/A
36 PCAS, France – 0.20 1 N/A
36 Cellenion SASU, France – 0.20 1 N/A
37 Inovarion SAS, France 0.17 0.19 3 8.8%
38 Oncomedics, France – 0.19 1 N/A
39 Glycodiag, France – 0.18 1 N/A
40 OSE Immunotherapeutics SA, France 0.18 0.18 1 -5.9%
41 Orange S.A., France – 0.17 1 N/A
42 Cis Bio International SA, France – 0.16 1 N/A
43 QuantaCell, France – 0.15 1 N/A
43 eV-Technologies, France – 0.15 1 N/A
44 Suez S.A., France 0.14 0.14 1 -3.2%
44 Mablink Bioscience SA, France – 0.14 1 N/A
44 ERM Poitiers, France – 0.14 1 N/A
44 Febus Optics SAS, France – 0.14 1 N/A
44 Agency for Consultation and Research in Oceanography (ACRO), France – 0.14 1 N/A
44 Société du Canal de Provence (SCP), France – 0.14 1 N/A
45 Seekyo SA, France – 0.13 2 N/A
46 Eliis SAS, France – 0.13 1 N/A
46 Mettler-Toledo SAS, France – 0.13 1 N/A
47 NanoMedSyn, France 0.04 0.12 2 217.3%
48 Xentech SAS, France 0.10 0.12 1 13.8%
49 Demeta S.A.S, France – 0.11 1 N/A
49 Greentech SA, France – 0.11 1 N/A
49 frec|n|sys SASU, France – 0.11 1 N/A
50 Kelenn Technology SARL, France 0.10 0.10 1 -3.2%
50 Magic LEMP, France – 0.10 1 N/A
50 LNC Therapeutics SA, France – 0.10 1 N/A
50 BioTransfer, France – 0.10 1 N/A
51 Sisprobe, France – 0.09 1 N/A
51 NEOVACS S.A., France – 0.09 1 N/A
51 BioAxial SAS, France – 0.09 1 N/A
52 Armines, France 0.07 0.09 6 19.6%
53 Groupe Roullier, France – 0.09 1 N/A
54 ViroScan3D SAS, France – 0.09 1 N/A
55 Atos SE, France – 0.08 1 N/A
55 C.Ris Pharma, France – 0.08 1 N/A
55 GenoSplice Technology SARL, France – 0.08 1 N/A
56 LABÉO, France – 0.08 1 N/A
57 Association pour le Développement de l’Enseignement et de la Recherche (ADERA), France – 0.07 1 N/A
57 Pixyl S.A., France – 0.07 2 N/A
58 Quandela SAS, France – 0.07 1 N/A
59 E-PHY-SCIENCE, France – 0.06 1 N/A
59 TransCure Biosciences, France – 0.06 1 N/A
60 Hprobe, France – 0.06 1 N/A
60 genOway, France – 0.06 1 N/A
60 Phyto-Quality SARL, France – 0.06 1 N/A
61 French National Railway Company (SNCF), France 0.03 0.05 1 69.3%
62 Gfi, France – 0.05 1 N/A
63 Multiwave Innovation SAS, France – 0.05 1 N/A
63 GRASP SAS, France – 0.05 1 N/A
64 CRYOSCAN SAS, France – 0.04 1 N/A
64 RS²D, France – 0.04 1 N/A
65 Ariana Pharma, France – 0.04 1 N/A
66 NovAliX, France – 0.04 1 N/A
67 Urolead SAS, France – 0.04 1 N/A
68 Antagene, France 0.07 0.04 1 -48.2%
69 Archeodunum SAS, France – 0.03 1 N/A
69 DNA Script SAS, France – 0.03 1 N/A
70 Genomic Vision, France – 0.03 1 N/A
71 Xenothera, France – 0.03 1 N/A
72 Imagine Optic SA, France – 0.02 1 N/A
73 CS Corporation, France – 0.02 1 N/A
73 Spin-Ion Technologies, France – 0.02 1 N/A
74 Jean Verdier Hospital, France 0.03 0.02 1 -33.8%
75 West Biotherapy, France – 0.02 1 N/A
76 BIOMICA SAS, France – 0.02 1 N/A
76 ALCEN, France – 0.02 1 N/A
77 DIGITEO, France – 0.01 1 N/A
78 ELISOL Environnement, France – 0.01 1 N/A
79 Eurobiomed, France 0.01 0.01 4 -39.0%
79 HalioDx SAS, France 0.06 0.01 4 -91.4%
80 Groupe RAGT, France 0.00 0.00 1 15.6%
80 Florimond Desprez, France 0.00 0.00 1 15.6%
80 Biogemma (BGA), France 0.00 0.00 1 15.6%
80 Limagrain, France 0.01 0.00 1 -79.6%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.